RT @RichardPAConway: Dr Lukas presents data showing possibility of tapering a range of TNF in AxSpA patients in remissio
Tweet Content
Dr Lukas presents data showing possibility of tapering a range of TNF in AxSpA patients in remission 162/184 (88.0%) LDA in progressive spacing group vs 173/189 (91.5%) in continued at 1 year.@RheumNow #EULAR2021 Abstr#0138
Show on Archive Page
On
Display in Search Results
On
PDQ
Off